{
    "title": "Epigenic Rejuvenation",
    "inventor_name": "Juan Carlos Izpisua Belmonte",
    "publication_year": 2016,
    "device_name": "Yamanaka-Factor Inducible Reprogramming System",
    "goal": "Reverse age-related epigenetic alterations to restore youthful tissue function and extend organismal lifespan.",
    "problem_addressed": "Age-associated decline, premature aging diseases (e.g., progeria), organ dysfunction and reduced lifespan.",
    "concept_summary": "Intermittent, doxycycline-controlled expression of the four Yamanaka transcription factors erases epigenetic marks, partially re-programming adult cells toward an embryonic state without full tumorigenesis, thereby rejuvenating tissues and extending lifespan in mouse models.",
    "detailed_description": "The method uses a transgenic mouse line that carries doxycycline-inducible constructs for the Yamanaka factors (Oct4, Sox2, Klf4, c-Myc). Mice are given doxycycline in drinking water either continuously or in a 2-day-on/5-day-off cycle. Continuous exposure leads to tumor formation and early death, whereas intermittent dosing yields partial epigenetic resetting, improved organ function (kidney, spleen, heart) and a ~30 % increase in lifespan for progeria mice. The approach is being extended to normal aged mice and to other disease models using CRISPR-based epigenome editors that modulate gene expression without altering DNA sequence.",
    "principles": [
        "Epigenetic reprogramming",
        "Inducible gene expression",
        "Partial cellular dedifferentiation",
        "CRISPR-Cas9 epigenome editing"
    ],
    "scientific_domains": [
        "Genetics",
        "Molecular Biology",
        "Epigenetics",
        "Regenerative Medicine",
        "Aging Biology"
    ],
    "mechanisms_of_action": [
        "Erasing DNA methylation and histone marks",
        "Resetting transcriptional programs to an embryonic-like state",
        "Transient activation of pluripotency factors",
        "Modulating gene expression via epigenome editors"
    ],
    "materials": [
        "Yamanaka transcription factor proteins (Oct4, Sox2, Klf4, c-Myc)",
        "Doxycycline (antibiotic inducer)",
        "Viral vectors / transgenic constructs (gene delivery)"
    ],
    "energy_sources": [],
    "inputs": [
        "Doxycycline administered in drinking water",
        "Genetic constructs encoding Yamanaka factors",
        "CRISPR-Cas9 epigenome-editing components"
    ],
    "outputs": [
        "Rejuvenated organs and tissues",
        "Extended lifespan (~=30 % longer in progeria mice)",
        "Improved organ function (kidney, spleen, heart)",
        "Reduced tumor incidence with intermittent dosing"
    ],
    "claimed_performance": "Mice with progeria lived ~30 % longer and showed better kidney, spleen and heart function when Yamanaka factors were expressed intermittently via doxycycline; continuous expression caused tumor formation and early death.",
    "experimental_evidence": "The article describes mouse experiments where doxycycline-induced Yamanaka factor expression was applied either continuously or intermittently; intermittent dosing produced rejuvenation phenotypes and lifespan extension, while continuous dosing resulted in fatal tumors.",
    "replication_status": "No independent replication reported; similar approaches are being explored by other labs but specific results are not detailed in the text.",
    "keywords": [
        "Epigenetic reprogramming",
        "Yamanaka factors",
        "Progeria",
        "Doxycycline inducible system",
        "iPSC",
        "Aging reversal",
        "Regenerative medicine"
    ],
    "related_technologies": [
        "Induced pluripotent stem cells (iPSC)",
        "CRISPR-Cas9 epigenome editing",
        "Gene therapy vectors",
        "Small-molecule epigenetic modulators"
    ],
    "controversy_level": "medium",
    "confidence_score": 0.85,
    "practicability_score": 0.6,
    "fringe_score": 0.4,
    "evidence_strength": 0.6,
    "risk_score": 0.5,
    "trl_estimate": 4,
    "source_urls": [
        "https://www.salk.edu/news-release/turning-back-time-salk-scientists-reverse-signs-aging/",
        "https://www.technologyreview.com/s/614074/scientist-fountain-of-youth-epigenome/"
    ],
    "organizations": [
        "Salk Institute for Biological Studies",
        "AgeX",
        "Turn Biotechnologies",
        "GenuCure"
    ],
    "applications": [
        "Treatment of age-related diseases",
        "Tissue regeneration",
        "Longevity therapy",
        "Therapeutic reversal of progeroid syndromes"
    ],
    "limitations": [
        "Tumor formation at high or continuous Yamanaka factor expression",
        "Efficacy demonstrated only in progeria mouse model, not in naturally aged animals",
        "Delivery of inducible factors to humans remains a challenge",
        "Long-term safety and off-target effects are unknown"
    ],
    "open_questions": [
        "Does epigenetic resetting address the root cause of aging or merely mask symptoms?",
        "Can the approach be safely applied to normally aged organisms?",
        "What is the optimal dosing schedule to balance rejuvenation and tumor risk?",
        "How will the technology be delivered and regulated in humans?"
    ],
    "red_flags": [
        "Potential for tumorigenesis due to loss of cellular identity",
        "Uncertainty about causality between epigenetic marks and aging",
        "Early-stage preclinical data with limited replication"
    ],
    "evidence_quotes": [
        "The mice that drank a limited dose did not develop tumors. Instead, they became more physically robust, their kidneys and spleens worked better, and their hearts pumped harder.",
        "In all, the treated mice also lived 30% longer than their littermates.",
        "The approach, which not only prompted human skin cells in a dish to look and behave young again, also resulted in the rejuvenation of mice with a premature aging disease, countering signs of aging and increasing the animals' lifespan by 30 percent."
    ],
    "category": "Longevity & Life Extension"
}